Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...

Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...

FUKUOKA, Japan, Jan. 05, 2026 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”) , a Japanese labor ...

For over 60 years, the search for an effective pharmacologic treatment for refractory or unexplained chronic cough has been ...

The cell and gene therapy market is at a pivotal point, with a surge in approvals and a maturing pipeline. While oncology ...

Enrollment on track in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis IND application for Descartes-08 in myositis accepted by FDA; seamless adaptive clinical trial offering potential ...

Tal Parnes, Chairman of the Board of Inspira Technologies, stated: “The contemplated acquisition of this liquid biopsy platform represents a significant value inflection point for Inspira, adding a ...

Meghan’s 2025 "American Riviera Orchard" launch became the ultimate case study in over-managed branding that lacks actual ...

FUKUOKA, Japan, Jan. 05, 2026 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) ("rYojbaba" or the "Company"), a Japanese labor consulting and health services company, today issued a letter to its ...

Universal Music chairman/CEO Lucian Grainge said that he will continue to focus on responsible AI initiatives in the face of evolving tech landscape.

There is a lot of debate about AI for mental health. Some say AI is aiding us, others disagree. A new view is to reframe as ...

Clint Bentley, Hikari, Noah Oppenheim and Will Tracy round out this year’s conversation highlighting some of the Oscar ...